DE3770937D1 - Tablette zur pharmazeutischen anwendung sukzessiver freisetzung. - Google Patents

Tablette zur pharmazeutischen anwendung sukzessiver freisetzung.

Info

Publication number
DE3770937D1
DE3770937D1 DE8787119166T DE3770937T DE3770937D1 DE 3770937 D1 DE3770937 D1 DE 3770937D1 DE 8787119166 T DE8787119166 T DE 8787119166T DE 3770937 T DE3770937 T DE 3770937T DE 3770937 D1 DE3770937 D1 DE 3770937D1
Authority
DE
Germany
Prior art keywords
casing
layer
tablet
pharmaceutical use
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787119166T
Other languages
English (en)
Inventor
Manna Aldo La
Paolo Colombo
Ubaldo Conte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMAIDEA Srl
Original Assignee
PHARMAIDEA Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMAIDEA Srl filed Critical PHARMAIDEA Srl
Application granted granted Critical
Publication of DE3770937D1 publication Critical patent/DE3770937D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8787119166T 1987-01-13 1987-12-23 Tablette zur pharmazeutischen anwendung sukzessiver freisetzung. Expired - Fee Related DE3770937D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19064/87A IT1201136B (it) 1987-01-13 1987-01-13 Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive

Publications (1)

Publication Number Publication Date
DE3770937D1 true DE3770937D1 (de) 1991-07-25

Family

ID=11154233

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787119166T Expired - Fee Related DE3770937D1 (de) 1987-01-13 1987-12-23 Tablette zur pharmazeutischen anwendung sukzessiver freisetzung.

Country Status (10)

Country Link
US (1) US4865849A (de)
EP (1) EP0274734B1 (de)
JP (1) JPS63190822A (de)
KR (1) KR880008805A (de)
AT (1) ATE64528T1 (de)
AU (1) AU610112B2 (de)
DE (1) DE3770937D1 (de)
ES (1) ES2031491T3 (de)
IT (1) IT1201136B (de)
NZ (1) NZ223160A (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8915716D0 (en) * 1989-07-08 1989-08-31 Coopers Animal Health Pharmaceutical compositions
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
SE464275B (sv) * 1989-07-31 1991-04-08 Aagerup Bengt Ny anvaendning av beta-receptorblockerare foer beredning av ett preparat verksamt mot menieres sjukdom
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
IE66933B1 (en) * 1990-01-15 1996-02-07 Elan Corp Plc Controlled absorption naproxen formulation for once-daily administration
US5198227A (en) * 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
US5213807A (en) * 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin
US5133892A (en) * 1990-10-17 1992-07-28 Lever Brothers Company, Division Of Conopco, Inc. Machine dishwashing detergent tablets
US5387421A (en) * 1991-01-31 1995-02-07 Tsrl, Inc. Multi stage drug delivery system
US5976571A (en) * 1991-01-31 1999-11-02 Port Systems, L.L.C. Method for making a multi-stage drug delivery system
US5674530A (en) * 1991-01-31 1997-10-07 Port Systems, L.L.C. Method for making a multi-stage drug delivery system
ATE122228T1 (de) * 1991-07-01 1995-05-15 Gergely Gerhard Verfahren zur herstellung einer pharmazeutischen zubereitung mit wenigstens zwei verschiedenen wirkstoffen und verwendung einer solchen zubereitung.
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5609884A (en) * 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
EP0695174B1 (de) * 1993-04-20 2003-03-19 TSRL, Inc. Mehrstufiges arzneistoffabgabesystem
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
US6183778B1 (en) 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
GB9401894D0 (en) 1994-02-01 1994-03-30 Rhone Poulenc Rorer Ltd New compositions of matter
EP0823255A4 (de) * 1995-04-03 1999-01-27 Chugai Pharmaceutical Co Ltd Sucralfat enthaltendes arzneimittel
AU746091B2 (en) * 1995-04-03 2002-04-18 Chugai Seiyaku Kabushiki Kaisha Sucralfate containing pharmaceutical composition
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
WO2000025752A1 (en) 1998-11-02 2000-05-11 Church, Marla, J. Multiparticulate modified release composition
SA99191255B1 (ar) 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
BRPI0015284B8 (pt) 1999-10-29 2021-05-25 Euro Celtique S/A formulações de hidrocodona de liberação controlada
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
KR101045144B1 (ko) 2000-10-30 2011-06-30 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US20040137062A1 (en) * 2001-05-25 2004-07-15 Sham Chopra Chronotherapy tablet and methods related thereto
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
BR0212951A (pt) 2001-09-28 2004-10-26 Mcneil Ppc Inc Formas de dosagens compósitas
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
CA2409552A1 (en) 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
ITMI20020514A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
US7157100B2 (en) * 2002-06-04 2007-01-02 J.B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical composition for controlled drug delivery system
CZ20041175A3 (cs) * 2002-06-04 2005-04-13 J.B. Chemicals & Pharmaceuticals Ltd. Farmaceutická kompozice pro systém pro řízené dávkování léčiva a způsob její výroby
DE10248652A1 (de) * 2002-10-18 2004-04-29 Solvay Interox Gmbh Verfahren zur Herstellung von staubfreien Erdalkaliperoxiden
JP5563735B2 (ja) 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド Ppi多回剤形
ES2703874T3 (es) 2004-08-23 2019-03-12 Pejo Iserlohn Heilmittel Und Diaet Gmbh & Co Kg Psicoestimulante que contiene una composición farmacéutica
WO2006055928A2 (en) * 2004-11-19 2006-05-26 Smithkline Beecham Corporation Pharmaceutical product
US20060233882A1 (en) * 2005-04-15 2006-10-19 Sowden Harry S Osmotic dosage form
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20090069275A1 (en) * 2006-02-17 2009-03-12 Rocca Jose G Low flush niacin formulation
UA96457C2 (ru) 2006-08-03 2011-11-10 Нитек Фарма Аг Лечение ревматоидного артрита глюкокортикоидами с отсроченным высвобождением
US8128460B2 (en) * 2006-09-14 2012-03-06 The Material Works, Ltd. Method of producing rust inhibitive sheet metal through scale removal with a slurry blasting descaling cell
WO2008067829A1 (en) * 2006-12-05 2008-06-12 Universita' Degli Studi Di Parma New modules, new assemblage kits and new assemblies for the controlled release of substances
PL2187873T3 (pl) 2007-08-13 2019-01-31 Abuse Deterrent Pharmaceutical Llc Leki odporne na nadużywanie, metoda stosowania i metoda wytwarzania
CN102014638A (zh) 2007-10-12 2011-04-13 武田制药北美公司 与食物摄入无关的治疗胃肠病症的方法
US20100233259A1 (en) * 2008-12-12 2010-09-16 Pascal Grenier Dosage form of ropinirole
CA2749646A1 (en) * 2009-01-26 2010-07-29 Nitec Pharma Ag Delayed-release glucocorticoid treatment of asthma
US20110311628A1 (en) 2009-03-09 2011-12-22 Council Of Scientific And Industrial Research Pulsatile release composition of therapeutic agent
CA2780347A1 (en) * 2009-12-07 2011-06-16 Mcneil-Ppc, Inc. Partial dip coating of dosage forms for modified release
HUE052301T2 (hu) 2012-02-22 2021-04-28 Duchesnay Inc Doxil-amin és piridoxin és/vagy metabolitjainak vagy sóinak készítmény
GB201303781D0 (en) 2013-03-04 2013-04-17 Gauthier Pierre Pascal Oral timer device and method of using same
US11571390B2 (en) 2013-03-15 2023-02-07 Othemo Life Sciences, Inc. Abuse deterrent compositions and methods of use
US10028941B2 (en) 2013-07-22 2018-07-24 Duchesnay Inc. Composition for the management of nausea and vomiting
WO2015016256A1 (ja) * 2013-07-30 2015-02-05 ライオン株式会社 錠剤
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
EP3452003A4 (de) * 2016-05-05 2019-06-26 Triastek, Inc. Dosierungsform mit kontrollierter freisetzung
CN116406260A (zh) * 2020-11-30 2023-07-07 Ss制药株式会社 含有布洛芬的固体制剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE564759A (de) * 1955-12-22
FR2100858B1 (de) * 1970-07-03 1975-06-06 Daiichi Seiyaku Co
JPS5333885Y2 (de) * 1974-08-01 1978-08-21
US4139589A (en) * 1975-02-26 1979-02-13 Monique Beringer Process for the manufacture of a multi-zone tablet and tablet manufactured by this process
HU174057B (hu) * 1976-09-17 1979-10-28 Richter Gedeon Vegyeszet Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva
DE3221425A1 (de) * 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4753790A (en) * 1986-12-16 1988-06-28 Warner-Lambert Company Sorbitol coated comestible and method of preparation
US4786911A (en) * 1987-11-10 1988-11-22 The Boeing Company Apparatus for circularly polarized radiation from surface wave transmission line

Also Published As

Publication number Publication date
JPS63190822A (ja) 1988-08-08
KR880008805A (ko) 1988-09-13
EP0274734A1 (de) 1988-07-20
ATE64528T1 (de) 1991-07-15
AU610112B2 (en) 1991-05-16
US4865849A (en) 1989-09-12
ES2031491T3 (es) 1992-12-16
EP0274734B1 (de) 1991-06-19
IT1201136B (it) 1989-01-27
AU1017988A (en) 1988-07-14
IT8719064A0 (it) 1987-01-13
NZ223160A (en) 1990-09-26

Similar Documents

Publication Publication Date Title
DE3770937D1 (de) Tablette zur pharmazeutischen anwendung sukzessiver freisetzung.
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
KR960009408B1 (en) Covered sustained-release preparation
KR900701325A (ko) 속방성 구강 투여용 정제
SE8703034L (sv) Oralt terapeutiskt system med systemisk verkan
NO915043L (no) Osmoseanordning for kontrollert avgivelse av et nyttig middel
KR880013586A (ko) 고체상태성질을 가진 제거 가능한 기질을 포함하는 투약기
EP0253541A3 (en) Sustained release pharmaceutical compositions in oral dosage form
EP0251680A3 (en) Controlled release bioerodible drug delivery system
ATE65023T1 (de) Pharmazeutische mittel.
HUP9904174A2 (hu) Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
KR900701274A (ko) 남용 가능성을 감소시킨 용량 제형
GT199900151A (es) Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial.
IE781163L (en) Sustained release of veterinary medicaments
DE69319258D1 (de) Vorrichtung zur kontrollierten freigabe
PT96921B (pt) Dispositivo de libertacao intermitente
ATE169818T1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
ATE88630T1 (de) Fester koerper mit ueberzogenem kern.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee